Case Name: TEVA PHARMACEUTICALS USA, INC., through its GATE PHARMACEUTICALS DIVISION, Plaintiff-Appellant, v. EISAI CO., LTD. and Eisai Medical Research, Inc., Defendants-Appellees
Court: United States Court of Appeals for the Federal Circuit
Jurisdiction: United States
Decision Date: 2011-07-21
Citations: 426 F. App'x 904
Docket Number: No. 2009-1593
Parties: TEVA PHARMACEUTICALS USA, INC., through its GATE PHARMACEUTICALS DIVISION, Plaintiff-Appellant, v. EISAI CO., LTD. and Eisai Medical Research, Inc., Defendants-Appellees.
Judges: 
Reporter: West's Federal Appendix
Volume: 426
Pages: 904–904

Head Matter:
TEVA PHARMACEUTICALS USA, INC., through its GATE PHARMACEUTICALS DIVISION, Plaintiff-Appellant, v. EISAI CO., LTD. and Eisai Medical Research, Inc., Defendants-Appellees.
No. 2009-1593.
United States Court of Appeals, Federal Circuit.
July 21, 2011.

Opinion:
ORDER
Upon consideration of the order of the Supreme Court of the United States in Eisai Co., Ltd., et al. v. Teva Phamaceuticals USA, Inc. Through its Gate Pharmaceuticals Division, — U.S. -, 131 S.Ct. 2991, 180 L.Ed.2d 818 (2011), vacating this court's judgment,
It is Ordered That:
(1) The mandate of this court issued on December 13, 2010 is recalled, the appeal is reinstated, and this court's October 6, 2010 judgment is vacated.
(2) The appeal is remanded to the district court with instructions to dismiss the complaint as moot.